Chlorothiazide (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Chlorothiazide drug offered from Fresenius Kabi USA, LLC. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: CHLOROTHIAZIDE SODIUM
SUBSTANCE NAME: CHLOROTHIAZIDE SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-10-21
END MARKETING DATE: 0000-00-00


Chlorothiazide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionChlorothiazide from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/18mL)
START MARKETING DATE: 2009-10-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-658_2c482eda-8793-4bf5-80af-69cd10e7ff26
PRODUCT NDC: 63323-658
APPLICATION NUMBER: ANDA090896

Other CHLOROTHIAZIDE SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Chlorothiazide Sodium
American Regent, Inc.Chlorothiazide Sodium
Fresenius Kabi USA, LLCChlorothiazide
Mylan Institutional LLCchlorothiazide sodium
Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)Sodium Diuril
Sagent Pharmaceuticalschlorothiazide sodium